Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C

The epithelial-mesenchymal transition (EMT) regulator, Slug, plays multifaceted roles in controlling lung cancer progression, but its downstream targets and mechanisms in promoting lung cancer progression have not been well defined. In particular, the miRNAs downstream of Slug in non-small cell lung...

Full description

Saved in:
Bibliographic Details
Published inCancer letters Vol. 402; pp. 190 - 202
Main Authors Chang, Tzu-Hua, Tsai, Meng-Feng, Gow, Chien-Hung, Wu, Shang-Gin, Liu, Yi-Nan, Chang, Yih-Leong, Yu, Sung-Liang, Tsai, Hsing-Chen, Lin, Shih-Wen, Chen, Yen-Wei, Kuo, Po-Yen, Yang, Pan-Chyr, Shih, Jin-Yuan
Format Journal Article
LanguageEnglish
Published Ireland Elsevier B.V 28.08.2017
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The epithelial-mesenchymal transition (EMT) regulator, Slug, plays multifaceted roles in controlling lung cancer progression, but its downstream targets and mechanisms in promoting lung cancer progression have not been well defined. In particular, the miRNAs downstream of Slug in non-small cell lung cancer (NSCLC) remain undetermined. Here, we report that miR-137 is downstream of the EMT regulator, Slug, in lung cancer cells. Slug binds directly to the E-box of the miR-137 promoter and up-regulates its expression in lung cancer cells. Knockdown of miR-137 abolished Slug-induced cancer invasion and migration, whereas upregulation of miR-137 was found to trigger lung cancer cell invasion and progression by direct suppressing TFAP2C (transcription factor AP-2 gamma). Clinical data showed that lung adenocarcinoma patients with low-level expression of Slug and miR-137 but high-level expression of TFAP2C experienced significantly better survival. miR-137 is a Slug-induced miRNA that relays the pro-metastatic effects of Slug by targeting TFAP2C. Our findings add new components to the Slug-mediated regulatory network in lung cancer, and suggest that Slug, miR-137, and TFAP2C may be useful prognostic markers in lung adenocarcinoma. •miR-137 is a Slug-induced miRNA in lung cancer cells.•Knockdown of miR-137 abolishes Slug-induced cancer cell invasion and migration.•miR-137 functions as an oncogene in lung cancer.•Slug-induced miR-137 enhances lung cancer progression by direct targeting TFAP2C.•Our findings add new components to the Slug regulatory network in lung cancer.
AbstractList The epithelial-mesenchymal transition (EMT) regulator, Slug, plays multifaceted roles in controlling lung cancer progression, but its downstream targets and mechanisms in promoting lung cancer progression have not been well defined. In particular, the miRNAs downstream of Slug in non-small cell lung cancer (NSCLC) remain undetermined. Here, we report that miR-137 is downstream of the EMT regulator, Slug, in lung cancer cells. Slug binds directly to the E-box of the miR-137 promoter and up-regulates its expression in lung cancer cells. Knockdown of miR-137 abolished Slug-induced cancer invasion and migration, whereas upregulation of miR-137 was found to trigger lung cancer cell invasion and progression by direct suppressing TFAP2C (transcription factor AP-2 gamma). Clinical data showed that lung adenocarcinoma patients with low-level expression of Slug and miR-137 but high-level expression of TFAP2C experienced significantly better survival. miR-137 is a Slug-induced miRNA that relays the pro-metastatic effects of Slug by targeting TFAP2C. Our findings add new components to the Slug-mediated regulatory network in lung cancer, and suggest that Slug, miR-137, and TFAP2C may be useful prognostic markers in lung adenocarcinoma.
The epithelial-mesenchymal transition (EMT) regulator, Slug, plays multifaceted roles in controlling lung cancer progression, but its downstream targets and mechanisms in promoting lung cancer progression have not been well defined. In particular, the miRNAs downstream of Slug in non-small cell lung cancer (NSCLC) remain undetermined. Here, we report that miR-137 is downstream of the EMT regulator, Slug, in lung cancer cells. Slug binds directly to the E-box of the miR-137 promoter and up-regulates its expression in lung cancer cells. Knockdown of miR-137 abolished Slug-induced cancer invasion and migration, whereas upregulation of miR-137 was found to trigger lung cancer cell invasion and progression by direct suppressing TFAP2C (transcription factor AP-2 gamma). Clinical data showed that lung adenocarcinoma patients with low-level expression of Slug and miR-137 but high-level expression of TFAP2C experienced significantly better survival. miR-137 is a Slug-induced miRNA that relays the pro-metastatic effects of Slug by targeting TFAP2C. Our findings add new components to the Slug-mediated regulatory network in lung cancer, and suggest that Slug, miR-137, and TFAP2C may be useful prognostic markers in lung adenocarcinoma. •miR-137 is a Slug-induced miRNA in lung cancer cells.•Knockdown of miR-137 abolishes Slug-induced cancer cell invasion and migration.•miR-137 functions as an oncogene in lung cancer.•Slug-induced miR-137 enhances lung cancer progression by direct targeting TFAP2C.•Our findings add new components to the Slug regulatory network in lung cancer.
The epithelial-mesenchymal transition (EMT) regulator, Slug, plays multifaceted roles in controlling lung cancer progression, but its downstream targets and mechanisms in promoting lung cancer progression have not been well defined. In particular, the miRNAs downstream of Slug in non-small cell lung cancer (NSCLC) remain undetermined. Here, we report that miR-137 is downstream of the EMT regulator, Slug, in lung cancer cells. Slug binds directly to the E-box of the miR-137 promoter and up-regulates its expression in lung cancer cells. Knockdown of miR-137 abolished Slug-induced cancer invasion and migration, whereas upregulation of miR-137 was found to trigger lung cancer cell invasion and progression by direct suppressing TFAP2C (transcription factor AP-2 gamma). Clinical data showed that lung adenocarcinoma patients with low-level expression of Slug and miR-137 but high-level expression of TFAP2C experienced significantly better survival. miR-137 is a Slug-induced miRNA that relays the pro-metastatic effects of Slug by targeting TFAP2C. Our findings add new components to the Slug-mediated regulatory network in lung cancer, and suggest that Slug, miR-137, and TFAP2C may be useful prognostic markers in lung adenocarcinoma.The epithelial-mesenchymal transition (EMT) regulator, Slug, plays multifaceted roles in controlling lung cancer progression, but its downstream targets and mechanisms in promoting lung cancer progression have not been well defined. In particular, the miRNAs downstream of Slug in non-small cell lung cancer (NSCLC) remain undetermined. Here, we report that miR-137 is downstream of the EMT regulator, Slug, in lung cancer cells. Slug binds directly to the E-box of the miR-137 promoter and up-regulates its expression in lung cancer cells. Knockdown of miR-137 abolished Slug-induced cancer invasion and migration, whereas upregulation of miR-137 was found to trigger lung cancer cell invasion and progression by direct suppressing TFAP2C (transcription factor AP-2 gamma). Clinical data showed that lung adenocarcinoma patients with low-level expression of Slug and miR-137 but high-level expression of TFAP2C experienced significantly better survival. miR-137 is a Slug-induced miRNA that relays the pro-metastatic effects of Slug by targeting TFAP2C. Our findings add new components to the Slug-mediated regulatory network in lung cancer, and suggest that Slug, miR-137, and TFAP2C may be useful prognostic markers in lung adenocarcinoma.
Abstract The epithelial-mesenchymal transition (EMT) regulator, Slug, plays multifaceted roles in controlling lung cancer progression, but its downstream targets and mechanisms in promoting lung cancer progression have not been well defined. In particular, the miRNAs downstream of Slug in non-small cell lung cancer (NSCLC) remain undetermined. Here, we report that miR-137 is downstream of the EMT regulator, Slug, in lung cancer cells. Slug binds directly to the E-box of the miR-137 promoter and up-regulates its expression in lung cancer cells. Knockdown of miR-137 abolished Slug-induced cancer invasion and migration, whereas upregulation of miR-137 was found to trigger lung cancer cell invasion and progression by direct suppressing TFAP2C (transcription factor AP-2 gamma). Clinical data showed that lung adenocarcinoma patients with low-level expression of Slug and miR-137 but high-level expression of TFAP2C experienced significantly better survival. miR-137 is a Slug-induced miRNA that relays the pro-metastatic effects of Slug by targeting TFAP2C. Our findings add new components to the Slug-mediated regulatory network in lung cancer, and suggest that Slug, miR-137, and TFAP2C may be useful prognostic markers in lung adenocarcinoma.
Author Tsai, Hsing-Chen
Chen, Yen-Wei
Chang, Yih-Leong
Wu, Shang-Gin
Kuo, Po-Yen
Yu, Sung-Liang
Liu, Yi-Nan
Tsai, Meng-Feng
Yang, Pan-Chyr
Lin, Shih-Wen
Gow, Chien-Hung
Shih, Jin-Yuan
Chang, Tzu-Hua
Author_xml – sequence: 1
  givenname: Tzu-Hua
  surname: Chang
  fullname: Chang, Tzu-Hua
  organization: Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei 10002, Taiwan
– sequence: 2
  givenname: Meng-Feng
  surname: Tsai
  fullname: Tsai, Meng-Feng
  organization: Department of Molecular Biotechnology, Da-Yeh University, Changhua 51591, Taiwan
– sequence: 3
  givenname: Chien-Hung
  orcidid: 0000-0001-6104-3459
  surname: Gow
  fullname: Gow, Chien-Hung
  organization: Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei 10002, Taiwan
– sequence: 4
  givenname: Shang-Gin
  surname: Wu
  fullname: Wu, Shang-Gin
  organization: Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei 10002, Taiwan
– sequence: 5
  givenname: Yi-Nan
  surname: Liu
  fullname: Liu, Yi-Nan
  organization: Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei 10002, Taiwan
– sequence: 6
  givenname: Yih-Leong
  surname: Chang
  fullname: Chang, Yih-Leong
  organization: Department of Pathology, National Taiwan University Hospital, National Taiwan University, Taipei 10002, Taiwan
– sequence: 7
  givenname: Sung-Liang
  surname: Yu
  fullname: Yu, Sung-Liang
  organization: Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei 10002, Taiwan
– sequence: 8
  givenname: Hsing-Chen
  surname: Tsai
  fullname: Tsai, Hsing-Chen
  organization: Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei 10002, Taiwan
– sequence: 9
  givenname: Shih-Wen
  surname: Lin
  fullname: Lin, Shih-Wen
  organization: Graduate Institute of Oncology, National Taiwan University, Taipei 10002, Taiwan
– sequence: 10
  givenname: Yen-Wei
  orcidid: 0000-0002-8740-0351
  surname: Chen
  fullname: Chen, Yen-Wei
  organization: Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei 10002, Taiwan
– sequence: 11
  givenname: Po-Yen
  surname: Kuo
  fullname: Kuo, Po-Yen
  organization: Department of Pathology, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin 64041, Taiwan
– sequence: 12
  givenname: Pan-Chyr
  surname: Yang
  fullname: Yang, Pan-Chyr
  organization: Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei 10002, Taiwan
– sequence: 13
  givenname: Jin-Yuan
  surname: Shih
  fullname: Shih, Jin-Yuan
  email: jyshih@ntu.edu.tw
  organization: Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei 10002, Taiwan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28610956$$D View this record in MEDLINE/PubMed
BookMark eNqVUtFqFDEUDVKx2-ofiAR88WXWm8kkkxERlsWqUFRs-xyymTvbrDOTNZkp7p_4uWZ2W4WCFCEkIfeck5tzckKOet8jIc8ZzBkw-Xozt6ZvcZjnwMo5yDlA_ojMmCrzrKwUHJEZcCgyrrg4JicxbgBAFKV4Qo5zJRlUQs7Ir6ttwPXYmsH5nvqGds4G_-3zImO8pPgzVWOcSqsdvWjHNd0G3_kBIx3Gzgfq-huzr5u-ph0OJqbh4qSU-s1iZ9qWWkxTO_Zrmlq2GPYHSeE6-HF9TeO4_XNN4l2eLb7my6fkcWPaiM9u11Nydfb-cvkxO__y4dNycZ5ZIYshq21jK9PkysgKmhzRQIMNglSlWYlaqaYuqpUVmKe9wbrMa8kFM7IRKpmw4qfk1UE3PezHiHHQnYtTf6ZHP0bNKqjKQgrOE_TlPejGj6FP3SUUq4pCcKES6sUtalx1WOttcJ0JO33neQK8OQCS0TEGbLR1w97_IRjXagZ6Clhv9CFgPQWsQeoUcCIX98h3-g_Q3h1omKy8cRh0tA5TFrULaAdde_e_ArZ1vbOm_Y47jH-N0DHXoC-mrzf9PFZy4KWaXv323wIP3_8bqj3s9Q
CitedBy_id crossref_primary_10_1016_j_snb_2024_135421
crossref_primary_10_2131_jts_43_281
crossref_primary_10_3389_fcell_2024_1427724
crossref_primary_10_3892_ijmm_2017_3187
crossref_primary_10_1016_j_aca_2023_341990
crossref_primary_10_3390_cancers14194809
crossref_primary_10_3892_ol_2018_9739
crossref_primary_10_1016_j_bbadis_2018_01_020
crossref_primary_10_3389_fimmu_2024_1464327
crossref_primary_10_3727_096504018X15195193936573
crossref_primary_10_3892_ol_2018_9559
crossref_primary_10_3390_biology10111200
crossref_primary_10_1186_s13046_022_02452_9
crossref_primary_10_1007_s12668_021_00921_7
crossref_primary_10_1016_j_heliyon_2023_e15725
crossref_primary_10_1016_j_omtn_2020_09_015
crossref_primary_10_3892_ijo_2023_5544
crossref_primary_10_3892_ol_2019_10478
crossref_primary_10_3390_ncrna4020014
crossref_primary_10_1177_1758835919850665
crossref_primary_10_1038_s41388_020_1228_1
crossref_primary_10_3390_cancers11020265
crossref_primary_10_1002_mgg3_1126
crossref_primary_10_1016_j_omtn_2018_08_020
crossref_primary_10_1042_BSR20181928
crossref_primary_10_1158_1541_7786_MCR_19_0359
crossref_primary_10_1186_s13046_019_1105_3
crossref_primary_10_18632_oncotarget_21954
crossref_primary_10_1186_s13046_018_0807_2
crossref_primary_10_1016_j_yexmp_2020_104411
crossref_primary_10_3390_molecules26195804
crossref_primary_10_1016_j_yexcr_2019_03_035
crossref_primary_10_1016_j_omtn_2020_06_028
crossref_primary_10_1016_j_prp_2022_154053
crossref_primary_10_1073_pnas_1913307116
crossref_primary_10_3390_cells12040667
crossref_primary_10_1016_j_jpba_2018_10_017
crossref_primary_10_1038_s41398_024_03175_5
crossref_primary_10_1177_2045894020951759
crossref_primary_10_3390_cancers12010209
crossref_primary_10_3389_fgene_2020_01023
crossref_primary_10_1186_s13046_018_0739_x
crossref_primary_10_1002_mc_23505
crossref_primary_10_3389_fendo_2022_930227
crossref_primary_10_1002_jcp_27855
Cites_doi 10.1245/ASO.2005.04.010
10.1038/sj.onc.1209091
10.1038/sj.bjc.6603193
10.1016/j.ccr.2007.12.008
10.1038/emboj.2011.102
10.1007/s13277-015-4611-8
10.1002/ijc.25452
10.1126/science.7513443
10.1186/s13578-015-0028-8
10.1038/nrm2868
10.1164/rccm.201009-1440OC
10.1124/pr.54.1.129
10.1038/ncomms2876
10.1093/carcin/bgr110
10.1038/onc.2010.215
10.1186/1476-4598-10-139
10.1186/1477-7819-11-12
10.3892/ol.2012.1026
10.3109/1061186X.2015.1057149
10.1038/onc.2015.59
10.1371/journal.pone.0096765
10.1128/MCB.01228-12
10.1186/2052-8426-2-7
10.1038/onc.2014.58
10.1038/sj.onc.1209534
10.3892/or.2016.4604
10.1093/nar/gkp803
10.1016/j.cell.2009.11.007
10.1016/j.cell.2005.09.029
10.1158/1078-0432.CCR-09-2638
10.1242/dev.061762
10.1007/s12094-015-1357-0
10.1371/journal.pone.0109734
10.1158/1078-0432.CCR-10-0230
10.18632/oncotarget.3943
10.1038/cddis.2013.144
10.1016/j.semcancer.2012.02.013
10.1158/1078-0432.CCR-05-0687
ContentType Journal Article
Copyright 2017 Elsevier B.V.
Elsevier B.V.
Copyright © 2017 Elsevier B.V. All rights reserved.
Copyright Elsevier Limited Aug 28, 2017
Copyright_xml – notice: 2017 Elsevier B.V.
– notice: Elsevier B.V.
– notice: Copyright © 2017 Elsevier B.V. All rights reserved.
– notice: Copyright Elsevier Limited Aug 28, 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TO
7U9
H94
K9.
NAPCQ
7X8
DOI 10.1016/j.canlet.2017.06.002
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
AIDS and Cancer Research Abstracts


MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1872-7980
EndPage 202
ExternalDocumentID 28610956
10_1016_j_canlet_2017_06_002
S0304383517303786
1_s2_0_S0304383517303786
Genre Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29B
4.4
457
4CK
4G.
5GY
5RE
5VS
6J9
6PF
7-5
71M
8FE
8FH
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABMZM
ABUDA
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACPRK
ACRLP
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADUVX
AEBSH
AEFWE
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AXJTR
BKEYQ
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
IH2
IHE
J1W
K-O
KOM
LK8
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OC~
OO-
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
ROL
RPZ
SCC
SDF
SDG
SDP
SEL
SES
SPCBC
SSH
SSU
SSZ
T5K
Z5R
~G-
.55
.GJ
3O-
3V.
53G
7RV
7X7
8C1
8FI
AACTN
AAQXK
ABWVN
ABXDB
ACRPL
ADMUD
ADNMO
AFCTW
AFFNX
AFJKZ
AFKRA
AFKWA
AGRDE
AI.
AJOXV
AMFUW
ASPBG
AVWKF
AZFZN
AZQEC
BBNVY
BENPR
BHPHI
FEDTE
FGOYB
FYUFA
G-2
GUQSH
HCIFZ
HED
HMK
HMO
HVGLF
HZ~
M1P
M2M
M2O
M7P
R2-
RIG
SAE
SEW
UDS
VH1
WUQ
X7M
ZGI
AAIAV
ABLVK
ABYKQ
AJBFU
DOVZS
EFLBG
LCYCR
AAYXX
AGQPQ
AGRNS
AIGII
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TO
7U9
H94
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c564t-dcfc9af28a690f2eea0fefe0687ab5d88fd49bc5e2d88aed72d6351a6f58861b3
IEDL.DBID .~1
ISSN 0304-3835
1872-7980
IngestDate Mon Jul 21 10:47:42 EDT 2025
Wed Aug 13 06:47:34 EDT 2025
Wed Feb 19 02:36:09 EST 2025
Tue Jul 01 02:29:34 EDT 2025
Thu Apr 24 23:09:44 EDT 2025
Fri Feb 23 02:33:48 EST 2024
Tue Feb 25 20:00:34 EST 2025
Tue Aug 26 17:11:33 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords Epithelial-mesenchymal transition (EMT)
miR-137
TFAP2C
Slug
Non-small cell lung cancer (NSCLC)
Language English
License Copyright © 2017 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c564t-dcfc9af28a690f2eea0fefe0687ab5d88fd49bc5e2d88aed72d6351a6f58861b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-6104-3459
0000-0002-8740-0351
PMID 28610956
PQID 1919445358
PQPubID 2031080
PageCount 13
ParticipantIDs proquest_miscellaneous_1909746533
proquest_journals_1919445358
pubmed_primary_28610956
crossref_citationtrail_10_1016_j_canlet_2017_06_002
crossref_primary_10_1016_j_canlet_2017_06_002
elsevier_sciencedirect_doi_10_1016_j_canlet_2017_06_002
elsevier_clinicalkeyesjournals_1_s2_0_S0304383517303786
elsevier_clinicalkey_doi_10_1016_j_canlet_2017_06_002
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-08-28
PublicationDateYYYYMMDD 2017-08-28
PublicationDate_xml – month: 08
  year: 2017
  text: 2017-08-28
  day: 28
PublicationDecade 2010
PublicationPlace Ireland
PublicationPlace_xml – name: Ireland
– name: Clare
PublicationTitle Cancer letters
PublicationTitleAlternate Cancer Lett
PublicationYear 2017
Publisher Elsevier B.V
Elsevier Limited
Publisher_xml – name: Elsevier B.V
– name: Elsevier Limited
References Liu, Lang, Qiu, Xu, Li, Tang (bib35) 2011; 128
Li, Zhang, Wang, Wang (bib36) 2016; 24
Wang, Yue, Yu, Wang, Wang (bib17) 2013; 11
Penna, Orso, Cimino, Tenaglia, Lembo, Quaglino (bib42) 2011; 30
Thiery, Acloque, Huang, Nieto (bib2) 2009; 139
Zaravinos (bib21) 2015; 2015
Tian, Zhang, Hurd, Hannenhalli, Liu, Lu (bib31) 2011; 138
Xiu, Liu, Xia, Jin, Yin, Zhao (bib37) 2014; 9
Bishop, Benjamin, Cholakh, Chajut, Clark, Westra (bib23) 2010; 16
Martin, Goyal, Watkins, Jiang (bib11) 2005; 12
Wang, Hsiao, Hong, Chen, Kao, Wang (bib25) 2014; 9
Wang, Huang, Kao, Hsu, Wang, Li (bib16) 2015; 34
Dong, Jin, Li, Ren, Liu (bib33) 2016; 35
Shih, Yang (bib3) 2011; 32
Schrem, Klempnauer, Borlak (bib29) 2002; 54
Tiwari, Gheldof, Tatari, Christofori (bib4) 2012; 22
Zhou, Liu, Wang, Ouyang (bib19) 2015; 5
Yu, Chen, Chang, Chen, Chen, Singh (bib22) 2008; 13
Wu, Heinrichs, Xu, Garrison, Zambetti, Adams (bib28) 2005; 123
Prislei, Martinelli, Zannoni, Petrillo, Filippetti, Mariani (bib8) 2015; 6
Merikallio, T, Pääkkö, Mäkitaro, Kaarteenaho, Lehtonen (bib27) 2014; 7
Lin, Chang, Chang, Lin, Chen, Pan (bib24) 2013; 4
Rothschild (bib32) 2014; 2
Shih, Tsai, Chang, Chang, Yuan, Yu (bib5) 2005; 11
Li, Watts, Oshiro, Futscher, Domann (bib41) 2006; 25
Kumar, Luo, Tudela, Alexander, Mendelson (bib30) 2013; 33
Park, Wu, Cyr, Woodfield, De Andrade, Spanheimer (bib40) 2015; 34
Nieto, Sargent, Wilkinson, Cooke (bib10) 1994; 64
Shioiri, Shida, Koda, Oda, Seike, Nishimura (bib12) 2006; 94
Yang, Li, Gao, Zhao, Zang, Zhang (bib38) 2015; 8
Norozi, Ahmadzadeh, Shahjahani, Shahrabi, Saki (bib9) 2016; 18
Zhang, Zhou, Tian, Liu, Xia (bib7) 2013; 5
Inui, Martello, Piccolo (bib20) 2010; 11
Wang, Lu, Qiu, Cui (bib26) 2010; 38
Su, Ku, Chen, Hsu, Hong, Chang (bib39) 2016; 6
Uygur, Wu (bib13) 2011; 10
Tirino, Camerlingo, Bifulco, Irollo, Montella, Paino (bib15) 2013; 4
Luo, Li, Dong, Sun (bib34) 2016; 37
Kosaka, Kikuchi, Mikami, Miyajima, Shirotake, Ishida (bib6) 2010; 16
Larue, Bellacosa (bib1) 2005; 20
Singh, Settleman (bib14) 2010; 29
Chang, Tsai, Su, Wu, Huang, Yu (bib18) 2011; 183
Shih (10.1016/j.canlet.2017.06.002_bib5) 2005; 11
Wu (10.1016/j.canlet.2017.06.002_bib28) 2005; 123
Inui (10.1016/j.canlet.2017.06.002_bib20) 2010; 11
Thiery (10.1016/j.canlet.2017.06.002_bib2) 2009; 139
Tian (10.1016/j.canlet.2017.06.002_bib31) 2011; 138
Norozi (10.1016/j.canlet.2017.06.002_bib9) 2016; 18
Nieto (10.1016/j.canlet.2017.06.002_bib10) 1994; 64
Uygur (10.1016/j.canlet.2017.06.002_bib13) 2011; 10
Dong (10.1016/j.canlet.2017.06.002_bib33) 2016; 35
Yu (10.1016/j.canlet.2017.06.002_bib22) 2008; 13
Park (10.1016/j.canlet.2017.06.002_bib40) 2015; 34
Kosaka (10.1016/j.canlet.2017.06.002_bib6) 2010; 16
Yang (10.1016/j.canlet.2017.06.002_bib38) 2015; 8
Larue (10.1016/j.canlet.2017.06.002_bib1) 2005; 20
Merikallio (10.1016/j.canlet.2017.06.002_bib27) 2014; 7
Schrem (10.1016/j.canlet.2017.06.002_bib29) 2002; 54
Zhang (10.1016/j.canlet.2017.06.002_bib7) 2013; 5
Wang (10.1016/j.canlet.2017.06.002_bib25) 2014; 9
Rothschild (10.1016/j.canlet.2017.06.002_bib32) 2014; 2
Kumar (10.1016/j.canlet.2017.06.002_bib30) 2013; 33
Shih (10.1016/j.canlet.2017.06.002_bib3) 2011; 32
Bishop (10.1016/j.canlet.2017.06.002_bib23) 2010; 16
Zhou (10.1016/j.canlet.2017.06.002_bib19) 2015; 5
Prislei (10.1016/j.canlet.2017.06.002_bib8) 2015; 6
Li (10.1016/j.canlet.2017.06.002_bib36) 2016; 24
Shioiri (10.1016/j.canlet.2017.06.002_bib12) 2006; 94
Luo (10.1016/j.canlet.2017.06.002_bib34) 2016; 37
Xiu (10.1016/j.canlet.2017.06.002_bib37) 2014; 9
Li (10.1016/j.canlet.2017.06.002_bib41) 2006; 25
Chang (10.1016/j.canlet.2017.06.002_bib18) 2011; 183
Liu (10.1016/j.canlet.2017.06.002_bib35) 2011; 128
Tirino (10.1016/j.canlet.2017.06.002_bib15) 2013; 4
Wang (10.1016/j.canlet.2017.06.002_bib17) 2013; 11
Singh (10.1016/j.canlet.2017.06.002_bib14) 2010; 29
Wang (10.1016/j.canlet.2017.06.002_bib26) 2010; 38
Zaravinos (10.1016/j.canlet.2017.06.002_bib21) 2015; 2015
Tiwari (10.1016/j.canlet.2017.06.002_bib4) 2012; 22
Penna (10.1016/j.canlet.2017.06.002_bib42) 2011; 30
Su (10.1016/j.canlet.2017.06.002_bib39) 2016; 6
Wang (10.1016/j.canlet.2017.06.002_bib16) 2015; 34
Lin (10.1016/j.canlet.2017.06.002_bib24) 2013; 4
Martin (10.1016/j.canlet.2017.06.002_bib11) 2005; 12
References_xml – volume: 183
  start-page: 1071
  year: 2011
  end-page: 1079
  ident: bib18
  article-title: Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor
  publication-title: Am. J. Respir. Crit. Care Med.
– volume: 38
  start-page: D119
  year: 2010
  end-page: D122
  ident: bib26
  article-title: TransmiR: a transcription factor-microRNA regulation database
  publication-title: Nucleic Acids Res.
– volume: 7
  start-page: 5846
  year: 2014
  end-page: 5854
  ident: bib27
  article-title: Slug is associated with poor survival in squamous cell carcinoma of the lung
  publication-title: Int. J. Clin. Exp. Pathol.
– volume: 6
  start-page: 18966
  year: 2015
  end-page: 18979
  ident: bib8
  article-title: Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer
  publication-title: Oncotarget
– volume: 24
  start-page: 102
  year: 2016
  end-page: 110
  ident: bib36
  article-title: MicroRNA-137 is downregulated in human osteosarcoma and regulates cell proliferation and migration through targeting FXYD6
  publication-title: J. Drug Target
– volume: 9
  start-page: e96765
  year: 2014
  ident: bib25
  article-title: MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinoma
  publication-title: PLoS One
– volume: 18
  start-page: 113
  year: 2016
  end-page: 124
  ident: bib9
  article-title: Twist as a new prognostic marker in hematological malignancies
  publication-title: Clin. Transl. Oncol.
– volume: 34
  start-page: 1116
  year: 2015
  end-page: 1125
  ident: bib16
  article-title: Slug is temporally regulated by cyclin E in cell cycle and controls genome stability
  publication-title: Oncogene
– volume: 128
  start-page: 1269
  year: 2011
  end-page: 1279
  ident: bib35
  article-title: miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells
  publication-title: Int. J. Cancer
– volume: 13
  start-page: 48
  year: 2008
  end-page: 57
  ident: bib22
  article-title: MicroRNA signature predicts survival and relapse in lung cancer
  publication-title: Cancer Cell
– volume: 30
  start-page: 1990
  year: 2011
  end-page: 2007
  ident: bib42
  article-title: microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C
  publication-title: EMBO J.
– volume: 139
  start-page: 871
  year: 2009
  end-page: 890
  ident: bib2
  article-title: Epithelial–mesenchymal transitions in development and disease
  publication-title: Cell
– volume: 123
  start-page: 641
  year: 2005
  end-page: 653
  ident: bib28
  article-title: Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma
  publication-title: Cell
– volume: 11
  start-page: 12
  year: 2013
  ident: bib17
  article-title: SLUG is activated by nuclear factor kappa B and confers human alveolar epithelial A549 cells resistance to tumor necrosis factor-alpha-induced apoptosis
  publication-title: World J. Surg. Oncol.
– volume: 6
  start-page: 1317
  year: 2016
  end-page: 1330
  ident: bib39
  article-title: Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma
  publication-title: Am. J. Cancer Res.
– volume: 2
  start-page: 7
  year: 2014
  ident: bib32
  article-title: microRNA therapies in cancer
  publication-title: Mol. Cell Ther.
– volume: 8
  start-page: 10847
  year: 2015
  end-page: 10853
  ident: bib38
  article-title: MicroRNA-137 inhibits cell migration and invasion by targeting bone morphogenetic protein-7 (BMP7) in non-small cell lung cancer cells
  publication-title: Int. J. Clin. Exp. Pathol.
– volume: 2015
  start-page: 865816
  year: 2015
  ident: bib21
  article-title: The regulatory role of MicroRNAs in EMT and cancer
  publication-title: J. Oncol.
– volume: 25
  start-page: 5405
  year: 2006
  end-page: 5415
  ident: bib41
  article-title: AP-2 alpha and AP-2 gamma are transcriptional targets of p53 in human breast carcinoma cells
  publication-title: Oncogene
– volume: 29
  start-page: 4741
  year: 2010
  end-page: 4751
  ident: bib14
  article-title: EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
  publication-title: Oncogene
– volume: 5
  start-page: 32
  year: 2015
  ident: bib19
  article-title: The roles of microRNAs in the regulation of tumor metastasis
  publication-title: Cell Biosci.
– volume: 16
  start-page: 610
  year: 2010
  end-page: 619
  ident: bib23
  article-title: Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach
  publication-title: Clin. Cancer Res.
– volume: 4
  start-page: 1877
  year: 2013
  ident: bib24
  article-title: MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1
  publication-title: Nat. Commun.
– volume: 16
  start-page: 5814
  year: 2010
  end-page: 5823
  ident: bib6
  article-title: Expression of snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasion
  publication-title: Clin. Cancer Res.
– volume: 4
  start-page: e620
  year: 2013
  ident: bib15
  article-title: TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction
  publication-title: Cell Death Dis.
– volume: 11
  start-page: 252
  year: 2010
  end-page: 263
  ident: bib20
  article-title: MicroRNA control of signal transduction
  publication-title: Nat. Rev. Mol. Cell Biol.
– volume: 20
  start-page: 7443
  year: 2005
  end-page: 7454
  ident: bib1
  article-title: Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways
  publication-title: Oncogene
– volume: 138
  start-page: 1235
  year: 2011
  end-page: 1245
  ident: bib31
  article-title: Regulation of lung endoderm progenitor cell behavior by miR302/367
  publication-title: Development
– volume: 64
  start-page: 835
  year: 1994
  end-page: 839
  ident: bib10
  article-title: Control of cell behavior during vertebrate development by Slug, a zinc finger gene
  publication-title: Science
– volume: 37
  start-page: 7749
  year: 2016
  end-page: 7755
  ident: bib34
  article-title: microRNA-137 is downregulated in thyroid cancer and inhibits proliferation and invasion by targeting EGFR
  publication-title: Tumour Biol.
– volume: 12
  start-page: 488
  year: 2005
  end-page: 496
  ident: bib11
  article-title: Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer
  publication-title: Ann. Surg. Oncol.
– volume: 34
  start-page: 6105
  year: 2015
  end-page: 6114
  ident: bib40
  article-title: The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis
  publication-title: Oncogene
– volume: 11
  start-page: 8070
  year: 2005
  end-page: 8078
  ident: bib5
  article-title: Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma
  publication-title: Clin. Cancer Res.
– volume: 32
  start-page: 1299
  year: 2011
  end-page: 1304
  ident: bib3
  article-title: The EMT regulator slug and lung carcinogenesis
  publication-title: Carcinogenesis
– volume: 5
  start-page: 564
  year: 2013
  end-page: 568
  ident: bib7
  article-title: High expression of ZEB1 correlates with liver metastasis and poor prognosis in colorectal cancer
  publication-title: Oncol. Lett.
– volume: 35
  start-page: 2151
  year: 2016
  end-page: 2158
  ident: bib33
  article-title: miR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12
  publication-title: Oncol. Rep.
– volume: 9
  start-page: e109734
  year: 2014
  ident: bib37
  article-title: MicroRNA-137 upregulation increases bladder cancer cell proliferation and invasion by targeting PAQR3
  publication-title: PLoS One
– volume: 22
  start-page: 194
  year: 2012
  end-page: 207
  ident: bib4
  article-title: EMT as the ultimate survival mechanism of cancer cells
  publication-title: Semin. Cancer Biol.
– volume: 94
  start-page: 1816
  year: 2006
  end-page: 1822
  ident: bib12
  article-title: Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients
  publication-title: Br. J. Cancer
– volume: 10
  start-page: 139
  year: 2011
  ident: bib13
  article-title: SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis
  publication-title: Mol. Cancer
– volume: 54
  start-page: 129
  year: 2002
  end-page: 158
  ident: bib29
  article-title: Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression
  publication-title: Pharmacol. Rev.
– volume: 33
  start-page: 1782
  year: 2013
  end-page: 1796
  ident: bib30
  article-title: The c-Myc-regulated microRNA-17∼92 (miR-17∼92) and miR-106a∼363 clusters target hCYP19A1 and hGCM1 to inhibit human trophoblast differentiation
  publication-title: Mol. Cell Biol.
– volume: 12
  start-page: 488
  year: 2005
  ident: 10.1016/j.canlet.2017.06.002_bib11
  article-title: Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer
  publication-title: Ann. Surg. Oncol.
  doi: 10.1245/ASO.2005.04.010
– volume: 20
  start-page: 7443
  year: 2005
  ident: 10.1016/j.canlet.2017.06.002_bib1
  article-title: Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1209091
– volume: 94
  start-page: 1816
  year: 2006
  ident: 10.1016/j.canlet.2017.06.002_bib12
  article-title: Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients
  publication-title: Br. J. Cancer
  doi: 10.1038/sj.bjc.6603193
– volume: 13
  start-page: 48
  year: 2008
  ident: 10.1016/j.canlet.2017.06.002_bib22
  article-title: MicroRNA signature predicts survival and relapse in lung cancer
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2007.12.008
– volume: 30
  start-page: 1990
  year: 2011
  ident: 10.1016/j.canlet.2017.06.002_bib42
  article-title: microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C
  publication-title: EMBO J.
  doi: 10.1038/emboj.2011.102
– volume: 37
  start-page: 7749
  year: 2016
  ident: 10.1016/j.canlet.2017.06.002_bib34
  article-title: microRNA-137 is downregulated in thyroid cancer and inhibits proliferation and invasion by targeting EGFR
  publication-title: Tumour Biol.
  doi: 10.1007/s13277-015-4611-8
– volume: 8
  start-page: 10847
  year: 2015
  ident: 10.1016/j.canlet.2017.06.002_bib38
  article-title: MicroRNA-137 inhibits cell migration and invasion by targeting bone morphogenetic protein-7 (BMP7) in non-small cell lung cancer cells
  publication-title: Int. J. Clin. Exp. Pathol.
– volume: 128
  start-page: 1269
  year: 2011
  ident: 10.1016/j.canlet.2017.06.002_bib35
  article-title: miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.25452
– volume: 7
  start-page: 5846
  year: 2014
  ident: 10.1016/j.canlet.2017.06.002_bib27
  article-title: Slug is associated with poor survival in squamous cell carcinoma of the lung
  publication-title: Int. J. Clin. Exp. Pathol.
– volume: 64
  start-page: 835
  year: 1994
  ident: 10.1016/j.canlet.2017.06.002_bib10
  article-title: Control of cell behavior during vertebrate development by Slug, a zinc finger gene
  publication-title: Science
  doi: 10.1126/science.7513443
– volume: 5
  start-page: 32
  year: 2015
  ident: 10.1016/j.canlet.2017.06.002_bib19
  article-title: The roles of microRNAs in the regulation of tumor metastasis
  publication-title: Cell Biosci.
  doi: 10.1186/s13578-015-0028-8
– volume: 11
  start-page: 252
  year: 2010
  ident: 10.1016/j.canlet.2017.06.002_bib20
  article-title: MicroRNA control of signal transduction
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/nrm2868
– volume: 183
  start-page: 1071
  year: 2011
  ident: 10.1016/j.canlet.2017.06.002_bib18
  article-title: Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/rccm.201009-1440OC
– volume: 54
  start-page: 129
  year: 2002
  ident: 10.1016/j.canlet.2017.06.002_bib29
  article-title: Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression
  publication-title: Pharmacol. Rev.
  doi: 10.1124/pr.54.1.129
– volume: 6
  start-page: 1317
  year: 2016
  ident: 10.1016/j.canlet.2017.06.002_bib39
  article-title: Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma
  publication-title: Am. J. Cancer Res.
– volume: 4
  start-page: 1877
  year: 2013
  ident: 10.1016/j.canlet.2017.06.002_bib24
  article-title: MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms2876
– volume: 32
  start-page: 1299
  year: 2011
  ident: 10.1016/j.canlet.2017.06.002_bib3
  article-title: The EMT regulator slug and lung carcinogenesis
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgr110
– volume: 29
  start-page: 4741
  year: 2010
  ident: 10.1016/j.canlet.2017.06.002_bib14
  article-title: EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
  publication-title: Oncogene
  doi: 10.1038/onc.2010.215
– volume: 10
  start-page: 139
  year: 2011
  ident: 10.1016/j.canlet.2017.06.002_bib13
  article-title: SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis
  publication-title: Mol. Cancer
  doi: 10.1186/1476-4598-10-139
– volume: 11
  start-page: 12
  year: 2013
  ident: 10.1016/j.canlet.2017.06.002_bib17
  article-title: SLUG is activated by nuclear factor kappa B and confers human alveolar epithelial A549 cells resistance to tumor necrosis factor-alpha-induced apoptosis
  publication-title: World J. Surg. Oncol.
  doi: 10.1186/1477-7819-11-12
– volume: 5
  start-page: 564
  year: 2013
  ident: 10.1016/j.canlet.2017.06.002_bib7
  article-title: High expression of ZEB1 correlates with liver metastasis and poor prognosis in colorectal cancer
  publication-title: Oncol. Lett.
  doi: 10.3892/ol.2012.1026
– volume: 24
  start-page: 102
  year: 2016
  ident: 10.1016/j.canlet.2017.06.002_bib36
  article-title: MicroRNA-137 is downregulated in human osteosarcoma and regulates cell proliferation and migration through targeting FXYD6
  publication-title: J. Drug Target
  doi: 10.3109/1061186X.2015.1057149
– volume: 34
  start-page: 6105
  year: 2015
  ident: 10.1016/j.canlet.2017.06.002_bib40
  article-title: The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis
  publication-title: Oncogene
  doi: 10.1038/onc.2015.59
– volume: 9
  start-page: e96765
  year: 2014
  ident: 10.1016/j.canlet.2017.06.002_bib25
  article-title: MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinoma
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0096765
– volume: 33
  start-page: 1782
  year: 2013
  ident: 10.1016/j.canlet.2017.06.002_bib30
  article-title: The c-Myc-regulated microRNA-17∼92 (miR-17∼92) and miR-106a∼363 clusters target hCYP19A1 and hGCM1 to inhibit human trophoblast differentiation
  publication-title: Mol. Cell Biol.
  doi: 10.1128/MCB.01228-12
– volume: 2
  start-page: 7
  year: 2014
  ident: 10.1016/j.canlet.2017.06.002_bib32
  article-title: microRNA therapies in cancer
  publication-title: Mol. Cell Ther.
  doi: 10.1186/2052-8426-2-7
– volume: 2015
  start-page: 865816
  year: 2015
  ident: 10.1016/j.canlet.2017.06.002_bib21
  article-title: The regulatory role of MicroRNAs in EMT and cancer
  publication-title: J. Oncol.
– volume: 34
  start-page: 1116
  year: 2015
  ident: 10.1016/j.canlet.2017.06.002_bib16
  article-title: Slug is temporally regulated by cyclin E in cell cycle and controls genome stability
  publication-title: Oncogene
  doi: 10.1038/onc.2014.58
– volume: 25
  start-page: 5405
  year: 2006
  ident: 10.1016/j.canlet.2017.06.002_bib41
  article-title: AP-2 alpha and AP-2 gamma are transcriptional targets of p53 in human breast carcinoma cells
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1209534
– volume: 35
  start-page: 2151
  year: 2016
  ident: 10.1016/j.canlet.2017.06.002_bib33
  article-title: miR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12
  publication-title: Oncol. Rep.
  doi: 10.3892/or.2016.4604
– volume: 38
  start-page: D119
  year: 2010
  ident: 10.1016/j.canlet.2017.06.002_bib26
  article-title: TransmiR: a transcription factor-microRNA regulation database
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkp803
– volume: 139
  start-page: 871
  year: 2009
  ident: 10.1016/j.canlet.2017.06.002_bib2
  article-title: Epithelial–mesenchymal transitions in development and disease
  publication-title: Cell
  doi: 10.1016/j.cell.2009.11.007
– volume: 123
  start-page: 641
  year: 2005
  ident: 10.1016/j.canlet.2017.06.002_bib28
  article-title: Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma
  publication-title: Cell
  doi: 10.1016/j.cell.2005.09.029
– volume: 16
  start-page: 610
  year: 2010
  ident: 10.1016/j.canlet.2017.06.002_bib23
  article-title: Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-09-2638
– volume: 138
  start-page: 1235
  year: 2011
  ident: 10.1016/j.canlet.2017.06.002_bib31
  article-title: Regulation of lung endoderm progenitor cell behavior by miR302/367
  publication-title: Development
  doi: 10.1242/dev.061762
– volume: 18
  start-page: 113
  year: 2016
  ident: 10.1016/j.canlet.2017.06.002_bib9
  article-title: Twist as a new prognostic marker in hematological malignancies
  publication-title: Clin. Transl. Oncol.
  doi: 10.1007/s12094-015-1357-0
– volume: 9
  start-page: e109734
  year: 2014
  ident: 10.1016/j.canlet.2017.06.002_bib37
  article-title: MicroRNA-137 upregulation increases bladder cancer cell proliferation and invasion by targeting PAQR3
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0109734
– volume: 16
  start-page: 5814
  year: 2010
  ident: 10.1016/j.canlet.2017.06.002_bib6
  article-title: Expression of snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasion
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-10-0230
– volume: 6
  start-page: 18966
  year: 2015
  ident: 10.1016/j.canlet.2017.06.002_bib8
  article-title: Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3943
– volume: 4
  start-page: e620
  year: 2013
  ident: 10.1016/j.canlet.2017.06.002_bib15
  article-title: TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction
  publication-title: Cell Death Dis.
  doi: 10.1038/cddis.2013.144
– volume: 22
  start-page: 194
  year: 2012
  ident: 10.1016/j.canlet.2017.06.002_bib4
  article-title: EMT as the ultimate survival mechanism of cancer cells
  publication-title: Semin. Cancer Biol.
  doi: 10.1016/j.semcancer.2012.02.013
– volume: 11
  start-page: 8070
  year: 2005
  ident: 10.1016/j.canlet.2017.06.002_bib5
  article-title: Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-05-0687
SSID ssj0005475
Score 2.440699
Snippet The epithelial-mesenchymal transition (EMT) regulator, Slug, plays multifaceted roles in controlling lung cancer progression, but its downstream targets and...
Abstract The epithelial-mesenchymal transition (EMT) regulator, Slug, plays multifaceted roles in controlling lung cancer progression, but its downstream...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 190
SubjectTerms 3' Untranslated Regions
Adenocarcinoma
Adenocarcinoma - genetics
Adenocarcinoma - metabolism
Adenocarcinoma - mortality
Adenocarcinoma - secondary
Adenocarcinoma of Lung
Animals
Antineoplastic Agents - pharmacology
Apoptosis
Arrays
Binding Sites
Biomarkers, Tumor - genetics
Biomarkers, Tumor - metabolism
Carcinoma, Non-Small-Cell Lung - genetics
Carcinoma, Non-Small-Cell Lung - metabolism
Carcinoma, Non-Small-Cell Lung - mortality
Carcinoma, Non-Small-Cell Lung - secondary
Cell cycle
Cell growth
Cell Line, Tumor
Cell Movement - drug effects
Cisplatin - pharmacology
Epithelial-mesenchymal transition (EMT)
Gene expression
Gene Expression Regulation, Neoplastic
Hematology, Oncology and Palliative Medicine
Humans
Kaplan-Meier Estimate
Kinases
Lung cancer
Lung Neoplasms - genetics
Lung Neoplasms - metabolism
Lung Neoplasms - mortality
Lung Neoplasms - pathology
Male
Medical prognosis
Mesenchyme
Metastases
Metastasis
Mice, Inbred NOD
Mice, SCID
MicroRNAs
MicroRNAs - genetics
MicroRNAs - metabolism
miR-137
miRNA
Neoplasm Invasiveness
Non-small cell lung cancer (NSCLC)
Non-small cell lung carcinoma
Promoter Regions, Genetic
Protein Binding
RNA Interference
Signal Transduction
Slug
Snail Family Transcription Factors - genetics
Snail Family Transcription Factors - metabolism
Survival
TFAP2C
Thyroid cancer
Time Factors
Transcription Factor AP-2 - genetics
Transcription Factor AP-2 - metabolism
Transcription factors
Transfection
Up-Regulation
Title Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0304383517303786
https://www.clinicalkey.es/playcontent/1-s2.0-S0304383517303786
https://dx.doi.org/10.1016/j.canlet.2017.06.002
https://www.ncbi.nlm.nih.gov/pubmed/28610956
https://www.proquest.com/docview/1919445358
https://www.proquest.com/docview/1909746533
Volume 402
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEA_HCeKL-O3qeUTwtW4_kiZ9XBaXVblFvFu4t5C2E1npdsu2FX3x7_DPdZKm64knJ761TSYJM9PJTPLLhJBXphC8RNUJ7FYJBiiCB1lueICTIcZbhieFw-acrdLlmr275JdHZD6ehbGwSm_7B5vurLX_MvXcnDabzfTcbuphfMUjVNJESJt2mzFhtfz19yswD-aS7drKga09Hp9zGC8cPXLHAryEy-LpF1eumZ7-5n66aWhxj9z1_iOdDUO8T46gfkBun_kd8ofkx7rZD9fLI8PpztCtRdx9XM2QTYLCV497rWn-jZ5X_SfaODwetLTrt7s93dRftCvXdUm30Gn0HttNa1uqd3XQbnVVUbvaTys0E7SwSrN3H7CF4c4f2vbNoRuku1jMPsTzR2S9eHMxXwb-9oWg4CnrgrIwRaZNLDUG0CYG0KEBA2Eqhc55iYIsWZYXHGJ81lCKuETnJdKp4VKmUZ48Jsc4MHhKKA9DEJKnmiUY7oDMRWoyKRgkgA3nMCHJyHRV-NTk9oaMSo0YtM9qEJWyolIOihdPSHCgaobUHDfU56M81XjsFA2lwrnjBjpxHR20_m9vVaTaWIXqD428SvmbUv9Dnyejwqlf3WRRxhhPuJyQl4diNAdWyLqGXW_rhBghpujET8iTQVEPzImlza3P02f_Pazn5I59s2vqsTwhx92-hxfolHX5qfvrTsmt2dv3y9VP1683aQ
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELaWRQIuiDeFBYzE1TQvP3KsKqoC2wqxrbQ3y0lsVJSmUZMguPA7-LmMHacsYtEiblHssa3xeDxjf55B6JXJOS1AdIi9KgEHhVOSZoYS2AzB3zI0zh02Z7Fk83Xy7pyeH6Hp8BbGwiq97u91utPW_s_Yc3NcbzbjM3upB_4VDUFIYy7YNXQ9geVr0xi8_n4B55G4aLu2NrHVh_dzDuQFwwf2WIQXd2E8_enKJfvT3-xPtw_N7qDb3oDEk36Md9GRru6hGwt_RX4f_VjX-z6_PHAc7wzeWsjdx-UE-MSx_uqBrxXOvuGzsvuEawfI0w1uu-1ujzfVF-XKVVXgrW4VmI_NprEtVbuKNFtVltge9-MS9ATOrdTs3Q9ooU_6g5uuPnQDdKvZ5EM0fYDWszer6Zz49AskpyxpSZGbPFUmEgo8aBNprQKjjQ6Y4CqjBcxkkaRZTnUE30oXPCrAegkVM1QIFmbxQ3QMA9OPEaZBoLmgTCUx-DtaZJyZVPBExxoazvQIxQPTZe5jk9sUGaUcQGifZT9V0k6VdFi8aITIgaruY3NcUZ8O8ymHd6egKSVsHlfQ8cvodOOXeyND2UQykH-I5EXK36T6H_o8GQRO_uomDdMEZJyKEXp5KAZ9YCdZVXrX2ToBuIgMrPgRetQL6oE5kbDB9Sl78t_DeoFuzleLU3n6dvn-KbplS-wBeyRO0HG77_QzsNDa7LlbgT8Bnic49w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Upregulation+of+microRNA-137+expression+by+Slug+promotes+tumor+invasion+and+metastasis+of+non-small+cell+lung+cancer+cells+through+suppression+of+TFAP2C&rft.jtitle=Cancer+letters&rft.au=Chang%2C+Tzu-Hua&rft.au=Tsai%2C+Meng-Feng&rft.au=Gow%2C+Chien-Hung&rft.au=Wu%2C+Shang-Gin&rft.date=2017-08-28&rft.pub=Elsevier+B.V&rft.issn=0304-3835&rft.eissn=1872-7980&rft.volume=402&rft.spage=190&rft.epage=202&rft_id=info:doi/10.1016%2Fj.canlet.2017.06.002&rft.externalDocID=S0304383517303786
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-3835&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-3835&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-3835&client=summon